Sec Form 4 Filing - Ripley Anne-Marie Juliette @ SECOND SIGHT MEDICAL PRODUCTS INC - 2015-05-26

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Ripley Anne-Marie Juliette 2. Issuer Name and Ticker or Trading Symbol SECOND SIGHT MEDICAL PRODUCTS INC [ EYES] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) VP Regulatory Affairs (Last) (First) (Middle) 12744 SAN FERNANDO ROAD, BLDG. 3 3. Date of Earliest Transaction (MM/DD/YY) 05/26/2015 (Street) SYLMAR, CA91342 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price COMMON STOCK 05/26/2015 M 8,716 ( 1 ) A $ 4.75 8,716 D COMMON STOCK 05/26/2015 S 8,716 ( 2 ) D $ 13.0283 ( 3 ) 0 D COMMON STOCK 05/27/2015 M 11,284 ( 1 ) A $ 4.75 11,284 D COMMON STOCK 05/27/2015 S 11,284 ( 2 ) D $ 13.039 ( 3 ) 0 D COMMON STOCK 05/27/2015 M 25,629 ( 1 ) A $ 4.75 25,629 D COMMON STOCK 05/27/2015 S 25,629 ( 2 ) D $ 13.039 ( 3 ) 0 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Option $ 4.75 05/26/2015 M 8,716 ( 1 ) ( 3 ) 09/01/2015 Common Stock 8,716 $ 0 124,410 D Option $ 4.75 05/27/2015 M 11,284 ( 1 ) ( 3 ) 09/01/2015 Common Stock 11,284 $ 0 113,126 D Option $ 4.75 05/27/2015 M 25,629 ( 3 ) 09/01/2015 Common Stock 25,629 $ 0 87,497 D Option $ 4.75 ( 3 ) 09/01/2015 Common Stock 4,371 87,497 D Option $ 4.75 ( 3 ) 01/01/2016 Common Stock 2,500 87,497 D Option $ 5 ( 3 ) 01/01/2017 Common Stock 6,125 87,497 D Option $ 5 ( 3 ) 04/01/2018 Common Stock 4,750 87,497 D Option $ 5 ( 3 ) 11/01/2018 Common Stock 25,000 87,497 D Option $ 5 ( 3 ) 02/01/2019 Common Stock 6,750 87,497 D Option $ 5 ( 3 ) 02/01/2020 Common Stock 10,125 87,497 D Option $ 5 ( 3 ) 02/01/2020 Common Stock 10,625 87,497 D Option $ 5 ( 3 ) 03/01/2021 Common Stock 8,313 87,497 D Option $ 5 ( 3 ) 03/01/2022 Common Stock 5,813 87,497 D Option $ 5 ( 3 ) 04/01/2024 Common Stock 5,813 87,497 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Ripley Anne-Marie Juliette 12744 SAN FERNANDO ROAD, BLDG. 3 SYLMAR, CA91342 VP Regulatory Affairs Signatures /s/ Anne-Marie Ripley 05/28/2015 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Ms. Ripley aquired 45,629 shares on exercise of options (which expire on September 1, 2015) reported as Option(1) on Form 3 filed with the SEC on November 18, 2014 and sold those shares as reported in Table I. ( 2 )These transactions were effected pursuant to planned sales under lock-up agreement entered into at the time of EYES IPO in November 2014, as approved by Board of EYES and the IPO underwriter. ( 3 )These are vested employee options currently exercisable.

Remarks: Excludes employee options in amount of 89,781 shares, not vested and not exercisable for over 60 days from this date.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.